Geodon Im 20 Mg/Ml Powder For Solution For Injection 20 mg/mL Powder for solution for injection
PDF Leaflet Revision Date: 23 January 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of schizophrenia.
Dosage (summary)
Initial: 40 mg twice daily with food; max: 80 mg twice daily.
Onset of Action / Duration
Onset: 6-8 hours, Duration: Not specified.
Special Populations
- Elderly: Caution advised.
- Renal impairment: No adjustment needed.
- Hepatic impairment: Lower doses may be needed.
Pregnancy & Breastfeeding
Not recommended; teratogenicity in animals; avoid breastfeeding.
Key Drug Interactions
- QT prolonging drugs.
- CNS depressants.
- Serotonergic medicines.
Contraindications
- Hypersensitivity to ziprasidone.
- QT interval prolongation.
- Recent myocardial infarction.
- Uncompensated heart failure.
Common side effects
- Somnolence.
- Akathisia.
- Dizziness.
- Nausea.
Counselling Points
- Take with food.
- Monitor for QT prolongation.
- Avoid alcohol.
Serious warnings
- QT prolongation risk.
- Neuroleptic Malignant Syndrome.
- Increased mortality in elderly with dementia-related psychosis.
Important Disclaimer
The Geodon Im 20 Mg/Ml Powder For Solution For Injection 20 mg/mL Powder for solution for injection professional information leaflet below is the property of Upjohn South Africa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
